Effects of BP on Modulating Sensitivity and Toxicity of Cisplatin and Regulating Immune Function in S180 Tumor-Bearing Mice

HUO Xiao-wei,WANG Can-hong,MA Xiao-ling,GAO Li,ZHANG Lei-lei,ZHANG Li-jing,LIU Dong-yu,HAN Jia-yuan,LI Li-yong,CAO Li

DOI: https://doi.org/10.3969/j.issn.1673-713x.2016.01.007

2016-01-01

Abstract:Objective To investigate the effects of BP on modulating sensitivity and toxicity of cisplatin and regulating immune function in S180 tumor-bearing mice. Method The S180 tumor-bearing mice model was established and consecutively administrated with BP alone (12.5, 50 mg/kg, i.p.), DDP alone (2 mg/kg, i.p.) or BP + DDP (25, 50, 100 mg/kg + 2 mg/kg) for 10 days. To evaluate the synergistic antitumor and attenuated effects of BP combined with DDP, peripheral white blood cells (WBC) and bone marrow nucleated cells were calculated. Also tumor, thymus and spleen were weighed and tumor inhibition rate, thymus and spleen index were measured, and ConA-induced T cells proliferation was also conducted by MTT assay. To evaluate the immune regulatory effect of BP, serum levels of IL-1β, IL-6 and TNF-α were detected by ELISA and phagocytic ratio of peritoneal macrophages was calculated. Result BP combined with DDP could significantly enhance the antitumor effect (P< 0.01). BP significantly reversed DDP-induced reduction of spleen index, WBC and bone marrow nucleated cells (P< 0.01 orP < 0.05). BP combined with DDP could also significantly improve T cells proliferation (P< 0.01 orP< 0.05). Moreover, BP couldobviously decrease levels ofIL-1β, IL-6 and TNF-α in serum (P< 0.01 orP< 0.05) and improve the phagocytic ratio (P< 0.01). Conclusion BP combined with DDP has synergistic antitumor effect and attenuated DDP-induced toxic effects in S180 tumor-bearing mice. Moreover, BP has immunomodulatory effects in S180 tumor-bearing mice.